Spectroscopic MRI, Proton Therapy, and Avastin for Recurrent Glioblastoma
- Status
- RECRUITING
- Phase
- NA
Clinical Trials Related to Recurrent Glioblastoma
Related studies linked through entity extraction aliases.
Mycophenolate Mofetil in Combination With Standard of Care for the Treatment of Glioblastoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Irinotecan And Bevacizumab Combined With Re-radiotherapy in Recurrent Glioblastoma
- Status
- UNKNOWN
- Phase
- PHASE1
GX-I7 in Combination With Bevacizumab in Recurrent Glioblastoma (GBM) Patients
- Status
- UNKNOWN
- Phase
- PHASE2
Combination of Stereotactic Radiosurgery and Enhanced Immunotherapy for Recurrent Glioblastomas(inSituVac2)(CSREIG)
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Study to Evaluate the Safety and Efficacy of ASC40 Tablets in Combination With Bevacizumab in Subjects With rGBM
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Nk Cell Therapy for Recurrent Glioblastoma Multiform Patients
- Status
- UNKNOWN
- Phase
- PHASE1
Natural Progesterone for the Treatment of Recurrent Glioblastoma
- Status
- TERMINATED
- Phase
- EARLY_PHASE1
Individualized Systems Medicine Functional Profiling for Recurrent Glioblastoma
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
Atezolizumab and Cabozantinib for the Treatment of Recurrent Glioblastoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Inducing a Hypothyroxinemic State in Patients With Recurrent Glioblastoma or Gliosarcoma
- Status
- WITHDRAWN
- Phase
- EARLY_PHASE1
Evaluate the Safety and Preliminary Efficacy of the Combination of NaviFUS System With Re-irradiation for rGBM Patients
- Status
- COMPLETED
- Phase
- NA
Combined Treatment of Camrelizumab and Bevacizumab for Adult Patients with Recurrent Glioblastoma (GBM)
- Status
- TERMINATED
- Phase
- PHASE2
BRiTE - Bispecific T Cell Engager for Patients With Glioblastoma
- Status
- RECRUITING
- Phase
- PHASE1
Neoadjuvant PD-1 Antibody Alone or Combined With DC Vaccines for Recurrent Glioblastoma
- Status
- UNKNOWN
- Phase
- PHASE2
ONC201 and Radiation Therapy Before Surgery for the Treatment of Recurrent Glioblastoma
- Status
- WITHDRAWN
- Phase
- PHASE1
Role of Repeat Resection in Recurrent Glioblastoma
- Status
- WITHDRAWN
- Phase
- NA
ASP8374 + Cemiplimab in Recurrent Glioma
- Status
- COMPLETED
- Phase
- PHASE1
Talazoparib - Carboplatin for Recurrent High-grade Glioma With DDRd
- Status
- COMPLETED
- Phase
- PHASE2
Testing the Addition of the Immune Therapy Drugs, Tocilizumab and Atezolizumab, to Radiation Therapy for Recurrent Glioblastoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2